Keyword Analysis & Research: sd101

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
sd1010.110.15826165

Keyword Research: People who searched sd101 also searched

Keyword CPC PCC Volume Score
sd1010.530.5741648

Search Results related to sd101 on Search Engine

  • SD-101 in Combination with Pembrolizumab in Advanced Mela…

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/30154193/

    WEBThis phase Ib trial evaluated intratumoral SD-101, a synthetic CpG oligonucleotide that stimulates Toll-like receptor 9 (TLR9), in combination with …

    DA: 26 PA: 42 MOZ Rank: 5

  • SD-101 - Investigational Therapeutic Candidate - Trisalus

    trisaluslifesci.com

    https://trisaluslifesci.com/candidate-sd-101/

    WEBSD-101, an investigational agent in development, is a toll-like receptor 9 (TLR9) agonist which is believed to bind to the TLR9 receptors found on …

    DA: 16 PA: 83 MOZ Rank: 88

  • SD-101 in Combination with Pembrolizumab in Advanced Mela…

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719557/

    WEBThis phase Ib trial evaluated intratumoral SD-101, a synthetic CpG oligonucleotide that stimulates Toll-like receptor 9 (TLR9), in combination with …

    DA: 88 PA: 73 MOZ Rank: 41

  • SD-101 Plus Pembrolizumab Elicits Responses in Head and Neck Canc…

    cancertherapyadvisor.com

    https://www.cancertherapyadvisor.com/home/cancer-topics/head-and-neck-cancer/head-neck-cancer-sd101-pembrolizumab-elicits-responses-treatment/

    WEBJanuary 11, 2022. The combination of pembrolizumab and intratumoral SD-101 produced responses in patients with recurrent or metastatic head and neck …

    DA: 34 PA: 13 MOZ Rank: 65

  • Phase 1b/2, open label, multicenter, study of the combination of SD-10…

    ascopubs.org

    https://ascopubs.org/doi/10.1200/JCO.2019.37.15_suppl.9534

    WEBMay 26, 2019 · Background: SD-101 is a synthetic CpG TLR9 agonist. Pembrolizumab is a PD-1 inhibitor. SYNERGY-001/KEYNOTE-184 …

    DA: 56 PA: 15 MOZ Rank: 44